背景:多药耐药(MDR)细菌被广泛认为是重要且紧迫的公共卫生问题。自古代吠陀时代以来,Tribulusstriris一直被用作传统医学中的健康补品。它也被用来合成小的,良好分散的金属纳米颗粒(NPs)。生物合成的氧化镍纳米颗粒(NiO-NP)具有广泛的生物医学用途。
目的:本研究的目的是利用绿色合成方法,使用Tribulusterstrap合成NiO-NP,随后表征,这项研究旨在评估这些NPs对多种药物耐药的伤口分离株的抗氧化和抗菌效果。
方法:通过滴定法合成NiO-NP,这是一种绿色的合成方法,它的特征是使用紫外-可见光谱(UV)等技术,傅里叶变换红外(FT-IR),扫描电子显微镜(SEM),X射线衍射(XRD)分析,和能量色散X射线(EDX)。使用2,2-二苯基-1-吡啶酰肼(DPPH)测定法评估了NP的抗氧化活性,和抗菌活性使用琼脂孔扩散法。IBMSPSSStatisticsforWindows,版本21(2012年发布;IBMCorp.,Armonk,纽约,美国)用于统计分析。
结果:生物合成的NiO-NP表现出从深棕色到深绿色的颜色变化,表明NPs的成功降低。在310-350nm处观察到UV分析峰,而FT-IR分析显示在各种波长如629.31cm-1(卤代化合物;C-Br拉伸)的峰,957.80cm-1(芳香族磷酸盐;P-O-C拉伸),1004.65cm-1(脂肪族磷酸盐;P-O-C拉伸),1094.93cm-1(有机硅氧烷或有机硅;Si-O-Si),1328.38cm-1(二烷基/芳基砜),1604.88cm-1(开链偶氮-N=N-),2928.68cm-1(亚甲基C-Hasym/sym拉伸),3268.65cm-1(正常聚合物“OH”拉伸)。NPs的结晶度确定为24.7%,而其余的75.6%表现出无定形结构。SEM图像显示纳米范围尺寸NiO-NP的球形团聚结构。EDX分析表明存在元素组成Ni(7.4%),O(39.4%),和C(53.3%)在生物合成的NiO-NP中。这些NPs对铜绿假单胞菌和肺炎克雷伯菌表现出显著的抗菌活性,对耐甲氧西林金黄色葡萄球菌(MRSA)具有中等抗菌活性,对粪肠球菌的抗菌活性最低。
结论:我们的体外结果表明,生物合成的NiO-NP具有显着的抗氧化和抗菌活性。这些NPs可以用作未来的抗菌药物,特别是针对肺炎克雷伯菌的MDR临床伤口分离株,铜绿假单胞菌,MRSA。
BACKGROUND: Multidrug-resistant (MDR) bacteria are widely acknowledged as a significant and pressing public health concern. Tribulus terrestris has been used as a health tonic in traditional medicine since ancient Vedic times. It was also utilized to synthesize small, well-dispersed metal nanoparticles (NPs). The biosynthesized nickel oxide nanoparticles (NiO-NPs) have a broad spectrum of biomedical uses.
OBJECTIVE: The objective of the research was to utilize a green synthesis method to synthesize NiO-NPs using Tribulus terrestris, subsequently characterize, and this study aimed to assess the antioxidant and antibacterial effectiveness of these NPs against wound isolates that are resistant to multiple drugs.
METHODS: The synthesis of NiO-NPs was achieved through the titration method, which is a green synthesis approach, and it was characterized by using techniques such as ultraviolet-visible spectroscopy (UV), Fourier transform infrared (FT-IR), scanning electron microscopy (SEM), X-ray diffraction (XRD) analysis, and energy dispersive X-ray (EDX). The antioxidant activity of the NPs was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, and antibacterial activity was done using the agar well diffusion method. IBM SPSS Statistics for Windows, Version 21 (Released 2012; IBM Corp., Armonk, New York, United States) is used for statistical analysis.
RESULTS: The biosynthesized NiO-NPs exhibited a color change from dark brown to dark green, indicating the successful reduction of the NPs. UV analysis peaks were observed at 310-350 nm, while FT-IR analysis showed the peaks at various wavelengths such as 629.31cm-1 (halo compound; C-Br stretching), 957.80cm-1(aromatic phosphates; P-O-C stretch), 1004.65cm-1 (aliphatic phosphates; P-O-C stretch), 1094.93cm-1 (organic siloxane or silicone; Si-O-Si), 1328.38cm-1 (dialkyl/aryl sulfones), 1604.88cm-1 (open-chain azo-N=N-), 2928.68cm-1 (methylene C-H asym/sym stretch), 3268.65cm-1 (normal polymeric \"OH\" stretch). The crystallinity of the NPs was determined to be 24.7%, while the remaining 75.6% exhibited an amorphous structure. The SEM image revealed a spherically agglomerated structure of the nano-ranged size NiO-NPs. The EDX analysis indicated the presence of elemental compositions Ni (7.4%), O (39.4%), and C (53.3%) in the biosynthesized NiO-NPs. These NPs demonstrated significant antibacterial activity against Pseudomonas aeruginosa and Klebsiella pneumoniae, moderate antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), and the lowest antibacterial activity against Enterococcus faecalis.
CONCLUSIONS: Our in vitro results demonstrate that the biosynthesized NiO-NPs exhibit significant antioxidant and antibacterial activity. These NPs can be used as a future antimicrobial medication, particularly against MDR clinical wound isolates of K. pneumoniae, P. aeruginosa, and MRSA.